Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.

Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.

<h4>Background</h4>The human respiratory syncytial virus (hRSV) is the leading cause of severe bronchiolitis in infants worldwide. The most severe RSV diseases occur between 2 and 6 months-of-age, so pediatric vaccination will have to be started within the first weeks after birth, when t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aude Remot, Xavier Roux, Catherine Dubuquoy, Jenna Fix, Stephan Bouet, Mohammed Moudjou, Jean-François Eléouët, Sabine Riffault, Agnès Petit-Camurdan
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/e8b59c5f1336419d9c4e58df6e4c0a5b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares